Frontiers in Endocrinology (Feb 2021)

Alternative RNA Splicing in Fatty Liver Disease

  • Panyisha Wu,
  • Moya Zhang,
  • Nicholas J. G. Webster,
  • Nicholas J. G. Webster,
  • Nicholas J. G. Webster

DOI
https://doi.org/10.3389/fendo.2021.613213
Journal volume & issue
Vol. 12

Abstract

Read online

Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression.

Keywords